News

Promotional graphic announcing an NIH Technology Transfer presentation at the Bio Innovation Conference. Learn about non-dilutive funding strategies from Sabarni Chatterjee, Deputy Director of the NIH Office of Technology Transfer. Event takes place October 23, 2026, in Bethesda, Maryland.

Beyond SBIRS: Non-Dilutive Funding Strategies to Advance Your Pipeline and Bottom Line

NIH OTT Deputy Director Sabarni Chatterjee will lead an interactive round table at the Maryland Tech Council’s Bio Innovation Conference focused on how you can receive non-dilutive support from the federal government without writing grants. Topics include: Partnerships providing indirect/in-kind
More
blank new placeholder image

Ebola Vaccine co-developed by NIH Well Tolerated by 1,500 adults in West Africa

Results from a large clinical trial in Liberia showed that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses that last for at least one year. One of the two vaccine candidate was co-developed by National Institute of Allergy and Infectious Diseases (NIAID)'s
More
blank new placeholder image

NIH SPARC Awards Help Treat Diseases Such as Pediatric Brain Tumors with Electrical Stimulation

The National Institutes of Health (NIH) announced $20 million in funding from the Stimulating Peripheral Activity to Relieve Conditions (SPARC) awards program. This program aims to transform our understanding of these nerve-organ interactions and ultimately advance the neuromodulation field toward
More
blank new placeholder image

NIH Receives 2017 "Deals of Distinction™" Award from the Licensing Executives Society

The 2017 Deals of Distinction™ Award was presented to National Institutes of Health, (NIH) along with its corporate partners, AbbVie and Biogen, for a license agreement related to the development and launch of Zinbryta® for treatment of relapsing multiple sclerosis (MS) The award, one of the most
More